Forcing Acute Myeloid Leukemia Cells to Run on Empty Shows Promise in Mice
Scientists have developed a new strategy against acute myeloid leukemia (AML) that pushes cancer cells to keep working even after their energy supply has been disrupted, causing them to die from metabolic stress.
Scientists have developed a new strategy against acute myeloid leukemia (AML) that pushes cancer cells to keep working even after their energy supply has been disrupted, causing them to die from metabolic stress. The study, published in the journal Molecular Cancer, reports promising results from laboratory and animal experiments.
This approach provides a potential new therapeutic strategy for patients with relapsed or refractory AML, particularly those with TP53‑mutated disease, who currently have very poor outcomes and limited treatment options.
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- Management of Acute Myeloid Leukemia: A Review
- Old cells, new tricks—important clue to AML diagnosis and cure discovered
- Treatment of Acute Myeloid Leukaemia
- Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates
- Research blog: Accelerating progress in AML